Hemagglutinin stalk-binding antibodies enhance effectiveness of neuraminidase inhibitors against influenza via Fc-dependent effector functions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hemagglutinin stalk-binding antibodies enhance effectiveness of neuraminidase inhibitors against influenza via Fc-dependent effector functions

Published:2022-08 Issue:8 Volume:3 Page:100718
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Zhang Ali,Chaudhari Hanu,Agung Yonathan,D’Agostino Michael R.,Ang Jann C.,Tugg Yona,Miller Matthew S.^ORCID

Funder

Boler Family Foundation

Michael G. DeGroote Institute for Infectious Disease Research, McMaster University

Canadian Institutes of Health Research

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference38 articles.

1. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study;Iuliano;Lancet,2018

2. The influenza virus hemagglutinin head evolves faster than the stalk domain;Kirkpatrick;Sci. Rep.,2018

3. A perspective on the structural and functional constraints for immune evasion: insights from the influenza virus;Wu;J. Mol. Biol.,2017

4. Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection;DiLillo;J. Clin. Invest.,2016

5. Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo;DiLillo;Nat. Med.,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influenza B Virus Vaccine Innovation through Computational Design;Pathogens;2024-09-02

2. Deciphering immune responses: a comparative analysis of influenza vaccination platforms;Drug Discovery Today;2024-09

3. Retracted and republished from: “The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs”;mBio;2024-05-08

4. A Universal Aptamer for Influenza A Viruses: Selection, Recognition, and Infection Inhibition;ACS Pharmacology & Translational Science;2023-12-29

5. The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs;mBio;2023-10-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3